A new modality for immunosuppression: targeting the JAK/STAT pathway
John J. O’Shea(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Marko Pesu(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Dominic Borie(Stanford University), Paul S. Changelian(Pfizer (United States))
Cited by 298
Abstract
Related Papers
No related papers found
Powered by citation graph analysis